Brief: Sartorius Stedim Biotech H1 Net Profit At EUR 154.1 Mln
July 22 (Reuters) - Sartorius Stedim Biotech SA STDM.PA: HALF-YEAR RESULTS 2025 OF SARTORIUS STEDIM BIOTECH H1 SALES REVENUE AT 1,490 MILLION EUROS, UP 9.4 PERCENT H1 UNDERLYING EBITDA INCREASES 19.3 PERCENT TO 462 MILLION EUROS MANAGEMENT CONFIRMS GUIDANCE FOR 2025 H1 NET PROFIT AT EUR 154.1 MILLION Source text: ID:nEQ1qfm46a Further company coverage: STDM.PA (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))